Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

C4orf30 Activators

C4orf30 Activators would refer to a class of molecules designed to modulate the activity of a protein encoded by the C4orf30 gene, which is shorthand for Chromosome 4, open reading frame 30. This gene would be situated on the fourth chromosome and represents one of the numerous open reading frames that potentially code for proteins. Activators in this context are chemical entities that interact with the C4orf30 protein to increase its natural biological activity. The mechanisms by which C4orf30 Activators could function are diverse: they might bind directly to the protein to induce a conformational change that results in increased activity, facilitate its interaction with other cellular components, or enhance the gene's expression to elevate protein levels. The development of such activators would likely be dependent on a detailed understanding of the protein's structure, including its active sites, regulatory regions, and any other relevant domains that could be targeted by small molecules or other types of chemical agents.

To embark on the creation of C4orf30 Activators, a substantial amount of foundational research would be required to uncover the role of the C4orf30 protein within the cell. This would encompass analyzing its expression patterns, localizing the protein within cellular compartments, and identifying any partners it interacts with. Advanced proteomics might be utilized to reveal the protein's function and post-translational modifications, while techniques like X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy could provide a detailed view of its three-dimensional structure. With such information at hand, the identification or design of activator molecules could proceed. This would involve using high-throughput screening to identify candidate molecules from large libraries of compounds or employing structure-based drug design to create novel compounds that fit specific regions of the protein. Following the initial identification, candidate activators would undergo a series of in vitro assays to assess their efficacy in terms of binding affinity, specificity, and the ability to increase the protein's activity. These compounds might also be tested in cellular assays to confirm that they can penetrate cells and activate C4orf30 within a complex biological environment. Through iterative rounds of synthesis and testing, optimized C4orf30 Activators could be developed, potentially providing useful tools for probing the function of the C4orf30 protein and enlightening our understanding of its role in cellular biology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

A proteasome inhibitor that could stabilize proteins, including DCAF16, by preventing their degradation.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Another proteasome inhibitor that may lead to the accumulation of ubiquitinated proteins, potentially affecting DCAF16.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Modulates the ubiquitin-proteasome system, possibly influencing the levels of proteins like DCAF16.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Induces ER stress and may affect protein folding, potentially impacting ubiquitin ligase complex components.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$76.00
$82.00
$367.00
36
(1)

A glucocorticoid that can modulate gene expression and protein stability, potentially affecting DCAF16 levels.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Exhibits various biological effects, including modulation of proteasome activity, which could influence DCAF16 expression.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Affects signaling pathways and could potentially modulate the expression of proteins involved in the ubiquitin-proteasome system.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$150.00
$286.00
$479.00
$1299.00
$8299.00
$915.00
22
(1)

Induces antioxidant response elements and might affect the expression of proteins involved in protein degradation pathways.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$52.00
$87.00
7
(1)

Can inhibit proteasome activity and might impact the levels of ubiquitin ligase complex proteins such as DCAF16.

Arsenic(III) oxide

1327-53-3sc-210837
sc-210837A
250 g
1 kg
$87.00
$224.00
(0)

Has been shown to affect proteasome activity and could potentially influence DCAF16 expression.